Related Experiment Video
Updated: Sep 5, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.5K
Skin Surface Dose for Whole Breast Radiotherapy Using Personalized Breast Holder: Comparison with Various
Chiu-Ping Chen1,2, Chi-Yeh Lin1, Chia-Chun Kuo1,3,4,5
1Department of Radiation Oncology, Wan Fang Hospital, Taipei Medical University, Taipei 110, Taiwan.
Cancers
|July 9, 2022
Summary
Personalized breast holders (PERSBRA) for radiotherapy reduce heart toxicity but increase skin surface dose. A larger mesh size in PERSBRA can mitigate this increased surface dose, benefiting patients undergoing breast cancer treatment.
Area of Science:
- Medical Physics
- Radiation Oncology
Background:
- Whole breast radiotherapy aims to protect normal organs, including the heart, while delivering effective treatment.
- Personalized breast holders (PERSBRA) offer a method for immobilizing the breast during radiotherapy.
- Evaluating the impact of PERSBRA on dose distribution, particularly skin surface dose, is crucial for optimizing treatment safety.
Purpose of the Study:
- To assess the skin surface dose in whole breast radiotherapy utilizing a personalized breast holder (PERSBRA).
- To compare the effects of different PERSBRA mesh sizes (large, fine, solid) on skin surface dose.
- To evaluate these effects across various radiotherapy techniques: hybrid, intensity-modulated radiotherapy (IMRT), and volumetric-modulated arc therapy (VMAT).
Main Methods:
- PERSBRA devices with three mesh sizes were designed and applied to an anthropomorphic phantom.
- Treatment plans were generated using hybrid, IMRT, and VMAT techniques for a total dose of 5000 cGy in 25 fractions.
- Dose measurements were performed using EBT3 film and thermoluminescent dosimeters (TLD) on the phantom with and without PERSBRA, analyzing tumor and surface doses.
Main Results:
- Tumor dose deviation remained within five percent across all measured techniques and configurations.
- The use of PERSBRA generally increased skin surface doses compared to no immobilization.
- A large mesh size PERSBRA demonstrated a reduction in skin surface dose compared to fine or solid mesh designs.
Conclusions:
- PERSBRA can reduce heart toxicity in breast radiotherapy but may increase skin surface dose.
- A larger mesh design for PERSBRA can help mitigate the build-up of skin surface doses.
- These findings are consistent across hybrid, IMRT, and VMAT radiotherapy techniques, offering guidance for clinical application.

